Treatment with oral anticoagulants and risk of mortality in COVID-19 patients
S. Altaraihi (Hellerup, Denmark), P. Kamstrup (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Jensen (Hellerup, Copenhagen, Denmark)
Source: International Congress 2022 – Miscellaneous: biomarkers for the management of chronic lung diseases
 
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Altaraihi (Hellerup, Denmark), P. Kamstrup (Hellerup, Denmark), J. Eklöf (Hellerup, Denmark), P. Sivapalan (Hellerup, Denmark), J. Jensen (Hellerup, Copenhagen, Denmark). Treatment with oral anticoagulants and risk of mortality in COVID-19 patients. 240
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|